Evidence map›Paper›PMID 29076785›Full record

ArticleJournal of neurosurgery2018

Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.

I Jonathan Pomeraniec, Hideyuki Kano, Zhiyuan Xu, Brandon Nguyen, Zaid A Siddiqui, Danilo Silva, Mayur Sharma, Hesham Radwan, Jonathan A Cohen, Robert F Dallapiazza and 13 more

Open access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of neurosurgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. A pilot study of [Clinical and translational radiation oncology · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 4 countries.

I Jonathan Pomeraniec1Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.
Hideyuki Kano8Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and.
Zhiyuan Xu1Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.
Brandon Nguyen2Department of Radiation Oncology, William Beaumont Hospital-Royal Oak, Michigan.
Zaid A Siddiqui2Department of Radiation Oncology, William Beaumont Hospital-Royal Oak, Michigan.
Danilo Silva3Cleveland Clinic Foundation, Center for Neurological Restoration, Cleveland, Ohio.
Mayur Sharma3Cleveland Clinic Foundation, Center for Neurological Restoration, Cleveland, Ohio.
Hesham Radwan3Cleveland Clinic Foundation, Center for Neurological Restoration, Cleveland, Ohio.
Jonathan A Cohen8Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and.
Robert F Dallapiazza1Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.
Christian Iorio-Morin6Department of Neurosurgery, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada.
Amparo Wolf4Department of Neurosurgery, NYU Langone Medical Center, New York, New York.
John A Jane1Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.
Inga S Grills2Department of Radiation Oncology, William Beaumont Hospital-Royal Oak, Michigan.
David Mathieu6Department of Neurosurgery, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada.
Douglas Kondziolka4Department of Neurosurgery, NYU Langone Medical Center, New York, New York.
Cheng-Chia Lee7Department of Neurosurgery, Taipei Veterans General Hospital, Taipei City, Taiwan.
Chih-Chun Wu7Department of Neurosurgery, Taipei Veterans General Hospital, Taipei City, Taiwan.
Christopher P Cifarelli9Department of Neurosurgery, West Virginia University Medical Center, Morgantown, West Virginia.
Tomas Chytka5Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic.
Gene H Barnett3Cleveland Clinic Foundation, Center for Neurological Restoration, Cleveland, Ohio.
L Dade Lunsford8Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and.
Jason P Sheehan1Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.
University of Virginia Health System · USBeaumont Hospital, Royal Oak · USFoundation Center · USUniversity of Pittsburgh Medical Center · USCentre Hospitalier Universitaire de Sherbrooke · CANYU Langone Health · USTaipei Veterans General Hospital · TWCleveland Clinic · USNa Homolce Hospital · CZWest Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

OBJECTIVE Gamma Knife radiosurgery (GKRS) is frequently used to treat residual or recurrent nonfunctioning pituitary macroadenomas. There is no consensus as to whether GKRS should be used early after surgery or if radiosurgery should be withheld until there is evidence of imaging-defined progression of tumor. Given the high incidence of adenoma progression after subtotal resection over time, the present study intended to evaluate the effect of timing of radiosurgery on outcome. METHODS This is a multicenter retrospective review of patients with nonfunctioning pituitary macroadenomas who underwent transsphenoidal surgery followed by GKRS from 1987 to 2015 at 9 institutions affiliated with the International Gamma Knife Research Foundation. Patients were matched by adenoma and radiosurgical parameters and stratified based on the interval between last resection and radiosurgery. Operative results, imaging data, and clinical outcomes were compared across groups following early (≤ 6 months after resection) or late (> 6 months after resection) radiosurgery. RESULTS After matching, 222 patients met the authors' study criteria (from an initial collection of 496 patients) and were grouped based on early (n = 111) or late (n = 111) GKRS following transsphenoidal surgery. There was a greater risk of tumor progression after GKRS (p = 0.013) and residual tumor (p = 0.038) in the late radiosurgical group over a median imaging follow-up period of 68.5 months. No significant difference in the occurrence of post-GKRS endocrinopathy was observed (p = 0.68). Thirty percent of patients without endocrinopathy in the early cohort developed new endocrinopathies during the follow-up period versus 27% in the late cohort (p = 0.84). Fourteen percent of the patients in the early group and 25% of the patients in the late group experienced the resolution of endocrine dysfunction after original presentation (p = 0.32). CONCLUSIONS In this study, early GKRS was associated with a lower risk of radiological progression of subtotally resected nonfunctioning pituitary macroadenomas compared with expectant management followed by late radiosurgery. Delaying radiosurgery may increase patient risk for long-term adenoma progression. The timing of radiosurgery does not appear to significantly affect the rate of delayed endocrinopathy.

Indexed as

Early Medical InterventionTime-to-TreatmentAdultAgedCohort StudiesEndoscopyFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm, ResidualOutcome and Process Assessment, Health CarePituitary NeoplasmsRadiosurgeryReoperationACTH = adrenocorticotrophic hormoneAP = anteroposteriorCC = craniocaudalGamma KnifeGKRS = Gamma Knife radiosurgerymacroadenomaNFPA = nonfunctioning pituitary adenomanonfunctioning pituitary adenomapituitary surgerySRS = stereotactic radiosurgerystereotactic radiosurgerytranssphenoidal surgeryTR = transverse

Identifiers

PMID29076785
PMCPMC5924422
OpenAlexW2767124386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.